Technology
Health
Biotechnology
ChemoCentryx
$10.919876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$10.91
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.41 (3.90%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell ChemoCentryx and other stocks, options, ETFs, and crypto commission-free!
About
ChemoCentryx, Inc. Common Stock, also called ChemoCentryx, is a biopharmaceutical company engages in the development and commercialization of medicines. Read More It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in Mountain View, CA.
Employees
76
Headquarters
Mountain View, California
Founded
1996
Market Cap
552.62M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
271.63K
High Today
$11.04
Low Today
$10.45
Open Price
$10.52
Volume
319.72K
52 Week High
$14.51
52 Week Low
$9.07
Collections
Technology
Health
Biotechnology
Top Movers
Biopharmaceutical
Cancer Prevention
Pharmaceutical
US
News
Seeking AlphaMar 12
ChemoCentryx, Inc. (CCXI) CEO Thomas Schall on Q4 2018 Results - Earnings Call Transcript
ChemoCentryx, Inc. (NASDAQ:CCXI) Q4 2018 Earnings Conference Call March 11, 2019 5:00 PM ET Company Participants William Slattery - Investor Relations, Burns McClellan Inc. Thomas Schall - Chairman, President and Chief Executive Officer Susan Kanaya - Executive Vice President, Chief Financial and Administrative Officer and Secretary Conference Call Participants Lina Kaminski - Canaccord Genuity LLC Steven Seedhouse - Raymond James & Associates, Inc. Dae Gon Ha - SVB Leerink LLC Edward Tenthoff - Pi...
The Motley FoolMar 12
ChemoCentryx (CCXI) Q4 2018 Earnings Conference Call Transcript
CHEMOCENTRYX INC (NASDAQ:CCXI) Q4 2018 Earnings Conference Call , 5:00 p.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good afternoon, and welcome to the ChemoCentryx Fourth Quarter and Full Year 2018 Financial Results Conference Call. At this time, all participants on a listen-only mode. Later, we'll conduct a question-and-answer session. As a reminder, this conference will be recorded. I would now like turn the call over to your host, Bill Sl...
Price Paid on Robinhood
6% Higher
Right Now
52 Week Low
$9.07
Average Price Paid
$10.26
52 Week High
$14.51
Earnings
-$0.27
$0.09
$0.44
$0.80
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.27 per share
Actual
-$0.21 per share